{"abstract": "The Swiss giant is putting three drugs in development into a new entity backed by investors. With biotech markets hot, there\u2019s room for copycat deals.", "web_url": "https://www.nytimes.com/2015/07/30/business/dealbook/novartis-spinoff-shows-alternative-to-big-drug-makers.html", "snippet": "The Swiss giant is putting three drugs in development into a new entity backed by investors. With biotech markets hot, there\u2019s room for copycat deals.", "lead_paragraph": "Biotechnology investors can be better than big pharmaceutical companies at valuing and nurturing small drugs. Recognizing this, Novartis is spinning three drugs in development into a new entity backed by British investors. With biotech markets hot, there\u2019s room for copycat deals.", "source": "The New York Times", "multimedia": [], "headline": {"main": "Novartis Spinoff Shows Alternative to Big Drug Makers", "kicker": "Breakingviews", "content_kicker": null, "print_headline": "", "name": null, "seo": null, "sub": null}, "keywords": [{"name": "subject", "value": "Drugs (Pharmaceuticals)", "rank": 1, "major": "N"}, {"name": "subject", "value": "Mergers, Acquisitions and Divestitures", "rank": 2, "major": "N"}, {"name": "subject", "value": "Biotechnology and Bioengineering", "rank": 3, "major": "N"}, {"name": "organizations", "value": "Novartis AG", "rank": 4, "major": "N"}, {"name": "organizations", "value": "Mereo BioPharma Group Ltd", "rank": 5, "major": "N"}], "pub_date": "2015-07-29T20:02:16+0000", "document_type": "article", "news_desk": "Business", "section_name": "Business Day", "subsection_name": "DealBook", "byline": {"original": "By Neil Unmack", "person": [{"firstname": "Neil", "middlename": null, "lastname": "Unmack", "qualifier": null, "title": null, "role": "reported", "organization": "", "rank": 1}], "organization": null}, "type_of_material": "News", "_id": "nyt://article/311dd382-193d-56c7-b593-181cc1833a79", "word_count": 338, "uri": "nyt://article/311dd382-193d-56c7-b593-181cc1833a79"}